Multiple formulary listings are a step forward to ensuring that postmenopausal women have access to medicines that address the unmet medical needs associated with osteoporosis MISSISSAUGA, ON – Amgen Canada… Read More
Canadians deserve a health care system that provides them with timely access to health services whenever and wherever they are needed, as well as the ability to age with dignity… Read More
Multiple DehydraTECH-GLP-1 and DehydraTECH-CBD formulations to be tested Chronic dosing over a 12-week treatment period Will assess weight loss and blood glucose level control Efficacy through possible brain absorption delivery… Read More
New positive clinical data demonstrate momentum on investigational once-daily, once-weekly and twice-yearly dosing strategies Key findings from studies evaluating potential future long-acting combination regimens affirm commitment to continuous biomedical innovation… Read More
Veklury was associated with a lower risk of developing long-COVID in one analysis – Veklury was associated with a reduced risk of mortality among people who are immunocompromised in a… Read More
